Clinical features of intracerebral hemorrhage during antithrombotic therapy: retrospective multicenter observational study (Research Grant for Cardiovascular Diseases (15C-1) from the Japanese Ministry of Health, Labour and Welfare)
スポンサーリンク
概要
- 論文の詳細を見る
To determine clininal features of Japanese patients who developed intracerebral hemorrhage (ICH) while receiving antithrombotic agents, we performed a retrospective study based on the medical records of 947 patients with nontraumatic ICH from 11 institutes between 1999 and 2003. On the treatment with antithrombotic therapy were 31.6% of the patients (20.7% of patients taking antiplatelets, 8.1% taking warfarin, and 2.5% taking both). The proportion of cerebellar hemorrhage to total ICH increased from 5% of the patients without antithrombotics to 9% of those on antithrombotic therapy (p=0.046). Advanced age (p<0.0001), male gender (p=0.0001), diabetes mellitus (p=0.045), history of ischemic stroke (p<0.0001), heart diseases (p<0.0001), and hematoma growth on computed tomography during the initial 24 hours (p=0.0043) were more frequent in ICH patients taking antithrombotic agents than in the others.
- 一般社団法人 日本脳卒中学会の論文
一般社団法人 日本脳卒中学会 | 論文
- Two cases with aphasia in the left putaminal damage and one case with visuospatial neglect in the right putaminal damage
- Alterations of plasma von Willebrand factor activity and the influence of anti-platelet drugs in acute cerebral infarction
- Carotid endarterectomy plaques correlation of clinical events and morphology.
- Stenting for stenosis of major cerebrovascular arteries.
- Cerebral infarction following antihypertensive therapy.